212 related articles for article (PubMed ID: 37839359)
1. Potential roles of the exosome/microRNA axis in breast cancer.
Mamalo AS; Alivirdiloo V; Sadeghnejad A; Hajiabbasi M; Gargari MK; Valilo M
Pathol Res Pract; 2023 Nov; 251():154845. PubMed ID: 37839359
[TBL] [Abstract][Full Text] [Related]
2. Blood Circulating Exosomes Contain Distinguishable Fractions of Free and Cell-Surface-Associated Vesicles.
Tamkovich S; Tutanov O; Efimenko A; Grigor'eva A; Ryabchikova E; Kirushina N; Vlassov V; Tkachuk V; Laktionov P
Curr Mol Med; 2019; 19(4):273-285. PubMed ID: 30868953
[TBL] [Abstract][Full Text] [Related]
3. Exosomal microRNA: a novel biomarker for breast cancer.
He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal cancer drug resistance: the role of exosomal miRNAs.
Salehi M; Vafadar A; Khatami SH; Taheri-Anganeh M; Vakili O; Savardashtaki A; Negahdari B; Naeli P; Behrouj H; Ghasemi H; Movahedpour A
Mol Biol Rep; 2022 Mar; 49(3):2421-2432. PubMed ID: 34850336
[TBL] [Abstract][Full Text] [Related]
7. Exosomes and exosomal RNAs in breast cancer: A status update.
Lakshmi S; Hughes TA; Priya S
Eur J Cancer; 2021 Feb; 144():252-268. PubMed ID: 33373870
[TBL] [Abstract][Full Text] [Related]
8. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
[TBL] [Abstract][Full Text] [Related]
9. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
10. Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review.
Francavilla A; Turoczi S; Tarallo S; Vodicka P; Pardini B; Naccarati A
Mutagenesis; 2020 Jul; 35(3):243-260. PubMed ID: 31784760
[TBL] [Abstract][Full Text] [Related]
11. Cell-to-cell communication: microRNAs as hormones.
Bayraktar R; Van Roosbroeck K; Calin GA
Mol Oncol; 2017 Dec; 11(12):1673-1686. PubMed ID: 29024380
[TBL] [Abstract][Full Text] [Related]
12. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.
Hwang S; Yang YM
Arch Pharm Res; 2021 Jun; 44(6):574-587. PubMed ID: 34165701
[TBL] [Abstract][Full Text] [Related]
13. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
[TBL] [Abstract][Full Text] [Related]
14. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
[TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNAs: novel players in cervical cancer.
Nahand JS; Vandchali NR; Darabi H; Doroudian M; Banafshe HR; Moghoofei M; Babaei F; Salmaninejad A; Mirzaei H
Epigenomics; 2020 Sep; 12(18):1651-1660. PubMed ID: 32957811
[TBL] [Abstract][Full Text] [Related]
16. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis.
Ghaemmaghami AB; Mahjoubin-Tehran M; Movahedpour A; Morshedi K; Sheida A; Taghavi SP; Mirzaei H; Hamblin MR
Cell Commun Signal; 2020 Aug; 18(1):120. PubMed ID: 32746854
[TBL] [Abstract][Full Text] [Related]
17. Exosome and exosomal microRNA: trafficking, sorting, and function.
Zhang J; Li S; Li L; Li M; Guo C; Yao J; Mi S
Genomics Proteomics Bioinformatics; 2015 Feb; 13(1):17-24. PubMed ID: 25724326
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
19. Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period.
Frørup C; Mirza AH; Yarani R; Nielsen LB; Mathiesen ER; Damm P; Svare J; Engelbrekt C; Størling J; Johannesen J; Mortensen HB; Pociot F; Kaur S
Front Immunol; 2021; 12():744509. PubMed ID: 34691048
[TBL] [Abstract][Full Text] [Related]
20. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
